Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies

Authors :: Ilaria Lenci
A. Di Biagio
Giuliano Rizzardini
L. Marinaro
C. D'Ambrosio
Fausto Baldanti
Ivana Maida
G.B. Gaeta
M. Puoti
T. Ruggiero
Mario Angelico
Vincenza Calvaruso
Laura Sticchi
Mario Starace
Giustino Parruti
P. Cacciatore
Nicola Caporaso
Caterina Pasquazzi
Stefania Paolucci
Anna Claudia Pellicelli
M. Andreoni
C. Masetti
Sergio Babudieri
Gabriella d'Ettorre
Francesco Santopaolo
Raffaele Cozzolongo
P. Andreone
Carlo Magni
Valeria Cento
Guido Gubertini
J. Vecchiet
Stefano Novati
Nicola Coppola
C.F. Perno
Bianca Bruzzone
F. De Leonardis
V. Pace Palitti
Marianna Aragri
A. Grieco
Pierluigi Tarquini
G. De Stefano
G. Raimondo
Teresa Pollicino
Alessia Giorgini
Giorgio Barbarini
Valeria Ghisetti
G. Verucchi
M.C. Sorbo
Savino Bruno
M. Paoloni
F. Ceccherini-Silberstein
Roberto Gulminetti
Antonio Craxì
Filomena Morisco
Manuela Merli
V.C. Di Maio
Vincenzo Sangiovanni
A. Ciancio
Simona Francioso
Simona Landonio
Aldo Bertoli
A. Mancon
Valeria Micheli
Antonio Picciotto
V. Boccaccio
M. Melis
Ennio Polilli
F.P. Antonucci
Dante Romagnoli
Silvia Barbaliscia
Source :: Digestive and Liver Disease. 49:e49-e50
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
Hepatology
business.industry
Interferon free
Gastroenterology
DIRECT ACTING ANTIVIRALS
03 medical and health sciences
0302 clinical medicine
Second line
030220 oncology & carcinogenesis
Internal medicine
Medicine
In real life
030211 gastroenterology & hepatology
business

Full Text Access

Tools